Examinant per Autoria "Bajorin, Dean F."
Mostrant 1 - 3 de 3
Resultats per pàgina
Opcions d'ordenació
Ítem Accés Obert Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma(Massachusetts Medical Society, 2017) Bellmunt Molins, Joaquim, 1959-; Bajorin, Dean F.; KEYNOTE-045 Investigators
Ítem Accés Obert Pembrolizumab versus chemotherapy in recurrent, advanced urothelial cancer in Japanese patients: a subgroup analysis of the phase 3 KEYNOTE-045(SpringerOpen, 2020) Nishiyama, Hiroyuki; Yamamoto, Yoshiaki; Sassa, Naoto; Nishimura, Kazuo; Nishimura, Kazuo; Fujimoto, Kiyohide; Fukasawa, Satoshi; Yokoyama, Minato; Enokida, Hideki; Takahashi, Kenichi; Tanaka, Yoshinobu; Imai, Kentaro; Shimamoto, Takashi; Perini, Rodolfo; Frenkl, Tara; Bajorin, Dean F.; Bellmunt Molins, Joaquim, 1959-
Ítem Accés Obert Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up(Elsevier, 2019) Fradet, Yves; Bellmunt Molins, Joaquim, 1959-; Bajorin, Dean F.